GSK
GSK plc NYSE Listed Mar 28, 1980$50.67
-2.84%
vs $52.15
Mkt Cap $104.3B
52w Low $36.20
57.9% of range
52w High $61.18
50d MA $52.66
200d MA $50.08
P/E (TTM)
18.6x
EV/EBITDA
9.9x
P/B
6.4x
Debt/Equity
1.1x
ROE
—
P/FCF
17.9x
RSI (14)
50.70
ATR (14)
$0.86
Beta
0.35
50d MA
$52.66
200d MA
$50.08
Avg Volume
3.8M
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
980 Great West Road · Brentford TW8 9GS · GB
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | TNS | 1.16 | 1.24 | +6.9% | 51.40 | +1.0% | +1.8% | -1.3% | -1.4% | -1.0% | +0.3% | — |
| Feb 4, 2026 | TNS | 0.64 | 0.68 | +6.2% | 57.23 | +1.0% | +3.4% | +1.8% | -2.0% | -0.3% | -0.6% | — |
| Oct 29, 2025 | TNS | 1.26 | 1.48 | +17.5% | 45.93 | +0.0% | +2.2% | -0.2% | -1.1% | +1.0% | -0.3% | — |
| Jul 30, 2025 | TNS | — | 0.96 | — | 38.97 | -3.9% | -4.7% | +1.1% | +0.3% | -1.0% | -1.5% | — |
| Apr 30, 2025 | TNS | 1.08 | 1.13 | +4.6% | 39.85 | -1.1% | -2.8% | +0.8% | -0.6% | -3.5% | -0.9% | — |
| Feb 5, 2025 | TNS | 0.44 | 0.59 | +34.1% | 37.70 | -0.5% | -3.5% | -0.9% | +1.2% | -1.1% | +0.2% | — |
| Oct 30, 2024 | TNS | 1.16 | 1.27 | +9.5% | 37.01 | -2.0% | -0.7% | +0.3% | +0.2% | +0.1% | -3.0% | — |
| Jul 31, 2024 | TNS | 1.00 | 1.09 | +9.0% | 38.77 | +0.3% | +2.2% | +2.0% | -2.6% | -1.8% | +1.8% | — |
| Jan 31, 2024 | TNS | 0.76 | 0.72 | -5.3% | 39.44 | +1.3% | +3.0% | +0.2% | +2.1% | +0.4% | +0.6% | — |
| Nov 1, 2023 | TNS | 1.09 | 1.26 | +15.6% | 34.58 | -1.7% | -1.2% | +0.8% | +1.0% | +0.5% | +0.2% | — |
| Jul 26, 2023 | TNS | 0.87 | 0.97 | +11.5% | 35.87 | +1.0% | +0.0% | -1.2% | +0.4% | -1.8% | -0.9% | — |
| Apr 26, 2023 | TNS | 0.82 | 0.90 | +9.8% | 35.93 | +0.3% | +0.2% | +0.1% | +0.5% | +0.4% | +1.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6 | Barclays | Downgrade | Equal Weight → Underweight | — | $49.02 | $50.69 | +3.4% | +3.1% | +0.1% | -0.8% | +0.3% | +0.0% |
| Nov 12 | Jefferies | Downgrade | Buy → Hold | — | $36.35 | $35.50 | -2.3% | -2.3% | -1.2% | -2.1% | -3.0% | +1.0% |
| Oct 31 | Guggenheim | Downgrade | Buy → Neutral | — | $37.01 | $36.27 | -2.0% | -0.7% | +0.3% | +0.2% | +0.1% | -3.0% |
| Jul 8 | UBS | Downgrade | Buy → Neutral | — | $38.84 | $38.85 | +0.0% | -0.3% | -0.3% | -0.1% | +0.9% | +0.7% |
| Jul 2 | Jefferies | Maintains | Buy → Buy | — | $38.38 | $38.11 | -0.7% | -0.4% | +0.7% | +1.0% | -0.3% | -0.3% |
| Mar 4 | Guggenheim | Upgrade | Neutral → Buy | — | $42.03 | $42.04 | +0.0% | +1.0% | +0.4% | +0.0% | +2.3% | -1.0% |
| Jan 3 | Jefferies | Upgrade | Hold → Buy | — | $37.51 | $38.11 | +1.6% | +3.8% | +0.4% | +0.4% | +1.1% | +0.3% |
| Feb 11 | DZ Bank | Downgrade | Buy → Hold | — | $44.44 | $44.37 | -0.2% | -0.3% | -3.2% | +1.7% | -0.5% | -0.2% |
| Nov 5 | Barclays | Upgrade | Underweight → Equal Weight | — | $43.00 | $43.00 | +0.0% | +1.1% | -1.7% | -0.1% | +1.1% | +0.1% |
| Mar 23 | SVB Leerink | Downgrade | Outperform → Market Perform | — | $36.67 | $36.25 | -1.1% | -1.9% | -0.3% | +0.6% | +1.7% | +0.1% |
| Feb 4 | Deutsche Bank | Downgrade | Hold → Sell | — | $35.42 | $35.74 | +0.9% | -0.1% | -0.3% | +0.6% | +0.8% | -0.6% |
| Jan 15 | Deutsche Bank | Maintains | Hold → Hold | — | $38.16 | $38.41 | +0.7% | +0.8% | +0.2% | -1.3% | -0.6% | +1.5% |
| Nov 21 | UBS | Upgrade | Neutral → Buy | — | $43.92 | $43.99 | +0.2% | +0.3% | -0.0% | +1.1% | +0.7% | +1.4% |
| Nov 11 | Argus | Maintains | Buy → Buy | — | $44.42 | $44.03 | -0.9% | -0.4% | +0.6% | +0.3% | -1.8% | +0.5% |
| Oct 16 | New Street | Upgrade | Reduce → Hold | — | $42.27 | $42.45 | +0.4% | +0.0% | +0.4% | +0.1% | +0.2% | -0.2% |
| Oct 11 | Cantor Fitzgerald | Upgrade | Hold → Buy | — | $42.25 | $42.15 | -0.2% | -0.2% | -0.0% | +0.2% | +0.0% | +0.4% |
| Sep 3 | Societe Generale | Upgrade | Sell → Buy | — | $41.58 | $41.81 | +0.6% | +2.0% | -0.1% | -0.7% | -0.0% | -1.4% |
| Jan 14 | Exane BNP Paribas | Downgrade | Outperform → Neutral | — | $39.38 | $38.73 | -1.7% | -2.0% | +1.1% | -1.6% | +1.5% | +0.2% |
| Dec 14 | Morgan Stanley | Maintains | Underweight → Underweight | — | $37.94 | $37.58 | -0.9% | -0.9% | -1.4% | +0.1% | +0.8% | +1.3% |
| Dec 14 | SunTrust Robinson Humphrey | Maintains | Hold → Hold | — | $37.94 | $37.58 | -0.9% | -0.9% | -1.4% | +0.1% | +0.8% | +1.3% |
| Dec 6 | Barclays | Downgrade | Overweight → Equal Weight | — | $38.34 | $37.00 | -3.5% | -2.4% | -0.3% | +1.0% | -0.8% | +0.9% |
| Aug 20 | Argus | Maintains | Buy → Buy | — | $41.25 | $41.21 | -0.1% | +0.2% | +0.4% | +0.1% | -0.9% | +0.3% |
| May 5 | Argus | Maintains | Buy → Buy | — | — | — | — | — | — | — | — | — |
| May 5 | Argus | Upgrade | Hold → Buy | — | — | — | — | — | — | — | — | — |
| Oct 26 | BofA Securities | Downgrade | Buy → Neutral | — | $38.19 | $37.29 | -2.4% | -4.2% | -1.0% | +1.3% | -0.7% | -0.6% |
| Jul 5 | Citigroup | Downgrade | Buy → Neutral | — | $42.77 | $42.35 | -1.0% | -0.3% | -0.9% | +0.0% | -0.1% | -0.5% |
| Sep 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $43.58 | $43.20 | -0.9% | -0.4% | -1.1% | +0.8% | +0.8% | -1.8% |
| Sep 14 | Exane BNP Paribas | Downgrade | Neutral → Underperform | — | $42.51 | $43.01 | +1.2% | +1.5% | +0.9% | -1.5% | +1.0% | -0.6% |
| Aug 12 | Argus | Maintains | Buy → Buy | — | $44.39 | $44.45 | +0.1% | -0.5% | +0.5% | -0.2% | +0.2% | +0.2% |
| Jul 14 | Jefferies | Upgrade | Hold → Buy | — | $43.75 | $44.13 | +0.9% | +0.3% | +0.1% | +0.7% | -1.2% | +0.9% |
| Feb 26 | Cantor Fitzgerald | Maintains | Hold → Hold | — | $39.50 | $39.32 | -0.5% | -0.9% | -1.2% | +2.6% | -0.7% | -0.6% |
| Jan 27 | Bryan Garnier | Upgrade | Neutral → Buy | — | $40.83 | $41.05 | +0.5% | -0.6% | +0.1% | +1.6% | +0.2% | -1.2% |
| Oct 20 | Credit Suisse | Upgrade | Underperform → Neutral | — | $41.74 | $41.94 | +0.5% | -1.4% | -0.7% | +1.4% | +1.6% | -0.1% |
| Oct 12 | JP Morgan | Upgrade | Underweight → Neutral | — | $40.22 | $40.00 | -0.5% | +0.4% | -0.7% | +1.3% | +2.3% | +1.0% |
| Jun 4 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $44.03 | $43.60 | -1.0% | -2.0% | -1.3% | -0.8% | -0.2% | +1.8% |
| Jul 28 | Mainfirst | Maintains | Underperform → Underperform | — | $48.60 | $48.67 | +0.1% | -0.8% | -0.4% | +0.9% | -0.2% | -0.7% |
| Apr 23 | Argus | Upgrade | Hold → Buy | — | $55.30 | $55.50 | +0.4% | -0.3% | +0.7% | +0.5% | +0.4% | +0.7% |
| Apr 22 | Panmure | Upgrade | Hold → Buy | — | $53.12 | $55.52 | +4.5% | +4.1% | -0.3% | +0.7% | +0.5% | +0.4% |
| Jan 27 | S&P Capital IQ | Upgrade | Sell → Hold | — | $53.33 | $53.38 | +0.1% | -0.4% | +0.3% | -2.3% | -0.2% | -0.8% |
| Jan 24 | Berenberg | Downgrade | Buy → Hold | — | $54.90 | $54.02 | -1.6% | -2.9% | -0.4% | +0.3% | -2.3% | -0.2% |
| Jan 22 | TD Cowen | Downgrade | Outperform → Market Perform | — | $54.95 | $55.00 | +0.1% | -0.4% | +0.3% | -2.9% | -0.4% | +0.3% |
| Jan 9 | UBS | Maintains | Neutral → Neutral | — | $52.73 | $53.27 | +1.0% | +0.2% | -0.2% | -1.7% | +1.3% | +1.5% |
| Dec 17 | Deutsche Bank | Downgrade | Buy → Hold | — | $51.89 | $51.07 | -1.6% | -1.6% | +0.6% | +0.4% | -0.4% | +0.4% |
| Nov 12 | Panmure | Downgrade | Buy → Hold | — | $53.03 | $52.01 | -1.9% | -1.6% | -0.5% | +0.4% | -0.1% | -0.1% |
| Oct 10 | Credit Suisse | Downgrade | Neutral → Underperform | — | $49.31 | $49.01 | -0.6% | +0.8% | +0.2% | +1.1% | -0.5% | +0.4% |
| Oct 8 | MainFirst | Upgrade | Underperform → Outperform | — | $50.13 | $49.94 | -0.4% | -1.2% | -0.5% | +0.8% | +0.2% | +1.1% |
| Sep 16 | Barclays | Downgrade | Overweight → Equal Weight | — | $51.41 | $51.87 | +0.9% | -0.2% | -0.3% | +0.3% | -2.0% | +0.5% |
| Aug 21 | TD Cowen | Upgrade | Market Perform → Outperform | — | $51.85 | $52.17 | +0.6% | +0.0% | +0.4% | +0.3% | -0.1% | -0.8% |
| Aug 15 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | $51.92 | $51.35 | -1.1% | -0.8% | +0.2% | -0.6% | +1.1% | +0.0% |
| Aug 14 | JP Morgan | Upgrade | Underweight → Neutral | — | $52.01 | $52.35 | +0.7% | -0.2% | -0.8% | +0.2% | -0.6% | +1.1% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Fmr Llc | 67,661,646 | $3.7B | — | Mar 2026 |
| 2 | Dodge & Cox | 58,662,974 | $3.2B | Reduced | Mar 2026 |
| 3 | Primecap Management Co/ca/ | 25,204,538 | $1.4B | — | Mar 2026 |
| 4 | Acadian Asset Management Llc | 11,797,085 | $651M | Added | Mar 2026 |
| 5 | Morgan Stanley | 11,657,326 | $572M | Added | Dec 2025 |
| 6 | Jtc Employer Solutions Trustee Ltd | 9,042,389 | $499M | New | Mar 2026 |
| 7 | Royal Bank Of Canada | 7,506,786 | $414M | Reduced | Mar 2026 |
| 8 | Mondrian Investment Partners Ltd | 4,987,393 | $275M | Reduced | Mar 2026 |
| 9 | Bank Of Montreal /can/ | 4,639,799 | $256M | Added | Mar 2026 |
| 10 | Grantham, Mayo, Van Otterloo & Co. Llc | 3,522,566 | $194M | Added | Mar 2026 |
| 11 | Equity Investment Corp | 3,221,035 | $178M | Reduced | Mar 2026 |
| 12 | Sei Investments Co | 2,286,880 | $126M | Added | Mar 2026 |
| 13 | Bank Of America Corp /de/ | 2,206,152 | $122M | Reduced | Mar 2026 |
| 14 | Ubs Group Ag | 2,084,235 | $115M | Reduced | Mar 2026 |
| 15 | Northern Trust Corp | 1,748,557 | $97M | Added | Mar 2026 |
| 16 | Bnp Paribas Financial Markets | 1,698,298 | $94M | Added | Mar 2026 |
| 17 | Letko, Brosseau & Associates Inc | 1,644,613 | $91M | Reduced | Mar 2026 |
| 18 | Miller Howard Investments Inc /ny | 1,629,351 | $90M | Reduced | Mar 2026 |
| 19 | Arrowstreet Capital, Limited Partnership | 1,621,397 | $89M | Reduced | Mar 2026 |
| 20 | Connor, Clark & Lunn Investment Management Ltd. | 1,737,118 | $85M | Added | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$104.30B
Enterprise Value
$115.59B
P/E (TTM)
18.63x
Forward P/E
10.47x
PEG Ratio
0.11x
P/B
6.42x
P/S
3.26x
P/FCF
17.91x
EV/EBITDA
9.95x
Shares Out
2.06B
Financials (TTM)
Revenue
$31.95B
Net Income
$5.59B
EBITDA
$11.62B
Free Cash Flow
$5.82B
Op Cash Flow
$7.14B
EPS Basic
$2.76
EPS Diluted
$2.72
EPS Forward
$4.84
Gross Margin
72.5%
Op Margin
21.9%
Net Margin
17.5%
Balance Sheet
Total Assets
$61.01B
Total Liab.
$45.02B
Total Equity
$15.93B
Cash
$3.40B
LT Debt
$14.68B
Book Value/Sh
$7.90
Debt/Equity
1.08x
Current Ratio
0.82
Quick Ratio
0.54
Returns & Growth
ROE
—
ROA
—
ROIC
14.0%
Rev Growth YoY
+1.8%
EPS Growth YoY
+119.0%
Price Returns
2W
-0.8%
1M
-3.4%
3M
-14.5%
6M
+5.6%
12M
+23.2%
Technicals
52W High
$61.18
52W Low
$36.20
50d MA
$52.66
200d MA
$50.08
RSI (14)
50.70
ATR (14)
$0.86
Beta
0.35
Avg Volume
3.8M
Dividends
Div Rate
$1.24
Div Yield
2.4%
Frequency
4
Ex-Div Date
Feb 20, 2026
Analyst Price Targets
Consensus
$52.45
High
$85.00
Low
$35.25
Median
$53.00
Data updated apr 26, 2026 10:46am
· Source: financialmodelingprep.com